The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-N-[[6-(chloromethyl)-7-nitro-1,2,3,4-tetrahydroquinolin-2-yl]methyl]propan-2-amine ID: ALA4871765
PubChem CID: 164622477
Max Phase: Preclinical
Molecular Formula: C21H26ClN3O2
Molecular Weight: 387.91
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)N(Cc1ccccc1)CC1CCc2cc(CCl)c([N+](=O)[O-])cc2N1
Standard InChI: InChI=1S/C21H26ClN3O2/c1-15(2)24(13-16-6-4-3-5-7-16)14-19-9-8-17-10-18(12-22)21(25(26)27)11-20(17)23-19/h3-7,10-11,15,19,23H,8-9,12-14H2,1-2H3
Standard InChI Key: ASOGHQZEYLASCM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
4.5357 -10.8117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5346 -11.6390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2493 -12.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2475 -10.3990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8205 -10.3996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1062 -10.8123 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8203 -9.5747 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8199 -12.0509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8192 -12.8758 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.9629 -10.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9662 -11.6365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6815 -12.0454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3978 -11.6306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3944 -10.8022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6746 -10.3886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1076 -10.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8233 -10.7977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5364 -10.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2521 -10.7934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5339 -9.5582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8258 -11.6227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5415 -12.0329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5407 -12.8585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2556 -13.2686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9697 -12.8539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9645 -12.0247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2491 -11.6183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 11 2 0
10 4 2 0
4 1 1 0
5 6 2 0
5 7 1 0
1 5 1 0
2 8 1 0
8 9 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 1 0
17 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M CHG 2 5 1 7 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 387.91Molecular Weight (Monoisotopic): 387.1714AlogP: 4.97#Rotatable Bonds: 7Polar Surface Area: 58.41Molecular Species: BASEHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.59CX LogP: 5.03CX LogD: 2.86Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.41Np Likeness Score: -0.92
References 1. Dziwornu GA, Attram HD, Gachuhi S, Chibale K.. (2020) Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?, 11 (4.0): [PMID:33479649 ] [10.1039/D0MD00062K ]